Idexx Laboratories (IDXX)

$647.40 +6.55 (1.02%)
Market Cap 51.27B
Revenue (ttm) 3.90B
Net Income (ttm) 887.87M
EPS (ttm) N/A
PE Ratio 53.17
Forward PE 50.64
Profit Margin 22.78%
Debt to Equity Ratio 0.36
Volume 452,600
Avg Vol 408,458
Day's Range N/A - N/A
Shares Out 80.01M
Stochastic %K 59%
Beta 1.58
Analysts Sell
Price Target $722.36

Company Profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test ki...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 207 556 0300
Fax: 207 556 4346
Address:
One IDEXX Drive, Westbrook, United States
darcypansy2
darcypansy2 Oct. 27 at 10:16 PM
$IDXX $CARR Upper shadow pressure https://stocktwits.com/jaredevans1/message/633847474
0 · Reply
VincentHall3771
VincentHall3771 Oct. 27 at 6:32 PM
$IDXX $CARR Swings initiated https://stocktwits.com/justinaugustus5/message/633849350
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 27 at 3:53 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $IDXX Current Share Price: $640.85 Contracts: $IDXX April 17, 2026 $650 Calls Scale in: $51.28- $62.67 Scale out: $79.77-$102.56 Can Easily Capture: 60% ROI Blended DTE: 173 Days | Join Elites here: https://liquidtheta.com
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 26 at 5:55 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $IDXX Current Share Price: $640.85 Contracts: $IDXX April 17, 2026 $650 Calls Scale in: $51.28- $62.67 Scale out: $79.77-$102.56 Can Easily Capture: 60% ROI Blended DTE: 174 Days | Join Elites here: https://liquidtheta.com
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 24 at 3:54 PM
🏛️ 🚀 $IDXX up ⬆️3.78% since our entry $626.34 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 24 at 3:34 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $IDXX Current Share Price: $639.30 Contracts: $IDXX April 17, 2026 $640 Calls Scale in: $58.66- $71.69 Scale out: $91.24-$117.31 Can Easily Capture: 60% ROI Blended DTE: 176 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 24 at 1:47 PM
$IDXX RSI: 60.09, MACD: 1.3880 Vol: 6.86, MA20: 633.06, MA50: 638.50 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 4:48 AM
Enter: $IDXX NOV 21 2025 $640 CALLS Buy in Price: $30.95 - $35.50 Take Profit: $73.04 Stop Bleeding: $27.24 ROI Potential: 136% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 21 at 11:56 PM
$IDXX Share Price: $636.91 Contract Selected: Apr 17, 2026 $640 Calls Buy Zone: $48.88 – $60.38 Target Zone: $90.48 – $110.58 Potential Upside: 75% ROI Time to Expiration: 177 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ZacksResearch
ZacksResearch Oct. 20 at 1:41 PM
$IDXX heading into Q3 with quiet strength 💪 Steady estimates and solid momentum in diagnostics and pet healthcare signal confidence ahead of earnings. Full pre-earnings breakdown here 👉 https://www.zacks.com/stock/news/2772097/heres-how-idexx-laboratories-is-placed-ahead-of-q3-earnings?cid=sm-stocktwits-2-2772097-teaser-16756&ADID=SYND_STOCKTWITS_TWEET_2_2772097_TEASER_16756
0 · Reply
Latest News on IDXX
IDEXX Laboratories to Release 2025 Third Quarter Financial Results

Oct 8, 2025, 2:00 PM EDT - 19 days ago

IDEXX Laboratories to Release 2025 Third Quarter Financial Results

IDEXX Laboratories Elects Karen Peacock to Board of Directors

Oct 7, 2025, 7:00 AM EDT - 20 days ago

IDEXX Laboratories Elects Karen Peacock to Board of Directors

IDEXX Laboratories, Inc. (IDXX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 5:24 PM EDT - 6 weeks ago

IDEXX Laboratories, Inc. (IDXX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 2, 2025, 1:00 PM EDT - 7 weeks ago

IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts

Aug 7, 2025, 9:35 PM EDT - 2 months ago

Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts

ARGX COO ELV HQY INSM ISRG RDNT

S&P 500 Gains and Losses Today: Retail Sector Stocks Rise Amid Rate Cut Hopes

Aug 4, 2025, 5:55 PM EDT - 3 months ago

S&P 500 Gains and Losses Today: Retail Sector Stocks Rise Amid Rate Cut Hopes

IDEXX Laboratories, Inc. (IDXX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 2:37 PM EDT - 3 months ago

IDEXX Laboratories, Inc. (IDXX) Q2 2025 Earnings Call Transcript

Final Trades: Delta Air Lines, Tesla, Idexx Lab and the IYF

Aug 4, 2025, 1:48 PM EDT - 3 months ago

Final Trades: Delta Air Lines, Tesla, Idexx Lab and the IYF

DAL IYF TSLA

Top Stock Movers Now: IDEXX, Wayfair, Berkshire Hathaway, and More

Aug 4, 2025, 12:15 PM EDT - 3 months ago

Top Stock Movers Now: IDEXX, Wayfair, Berkshire Hathaway, and More

W

IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation

Aug 4, 2025, 10:45 AM EDT - 3 months ago

IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation

IDEXX Laboratories Stock Jumps as Pet Health Care Firm Lifts Full-Year Outlook

Aug 4, 2025, 9:10 AM EDT - 3 months ago

IDEXX Laboratories Stock Jumps as Pet Health Care Firm Lifts Full-Year Outlook

IDEXX Laboratories raises annual forecasts on strong demand for pet diagnostics

Aug 4, 2025, 7:57 AM EDT - 3 months ago

IDEXX Laboratories raises annual forecasts on strong demand for pet diagnostics

IDEXX Laboratories Announces Second Quarter Results

Aug 4, 2025, 6:30 AM EDT - 3 months ago

IDEXX Laboratories Announces Second Quarter Results

IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals

Jul 30, 2025, 7:00 AM EDT - 3 months ago

IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals

IDEXX Laboratories: A Business With Strong Fundamentals

Jul 17, 2025, 7:06 AM EDT - 3 months ago

IDEXX Laboratories: A Business With Strong Fundamentals

IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors

Jul 10, 2025, 7:00 AM EDT - 3 months ago

IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors

IDEXX Laboratories to Release 2025 Second Quarter Financial Results

Jun 24, 2025, 1:00 PM EDT - 4 months ago

IDEXX Laboratories to Release 2025 Second Quarter Financial Results

Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

Jun 5, 2025, 7:00 AM EDT - 5 months ago

Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits

May 14, 2025, 2:35 PM EDT - 5 months ago

IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits

IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day

May 13, 2025, 2:30 PM EDT - 5 months ago

IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day

IDEXX Laboratories, Inc. (IDXX) Q1 2025 Earnings Conference Call Transcript

May 1, 2025, 10:35 AM EDT - 6 months ago

IDEXX Laboratories, Inc. (IDXX) Q1 2025 Earnings Conference Call Transcript

IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics

May 1, 2025, 8:21 AM EDT - 6 months ago

IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics

IDEXX Laboratories Announces First Quarter Results

May 1, 2025, 6:30 AM EDT - 6 months ago

IDEXX Laboratories Announces First Quarter Results

IDEXX Laboratories to Release 2025 First Quarter Financial Results

Apr 3, 2025, 1:30 PM EDT - 7 months ago

IDEXX Laboratories to Release 2025 First Quarter Financial Results

IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To 'Buy'

Mar 17, 2025, 5:40 AM EDT - 8 months ago

IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To 'Buy'

IDEXX Laboratories: A Top Dog In The Pet Care Market

Mar 12, 2025, 6:24 AM EDT - 8 months ago

IDEXX Laboratories: A Top Dog In The Pet Care Market

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

Feb 13, 2025, 2:00 PM EST - 9 months ago

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

IDEXX Laboratories And Its Real Value

Feb 10, 2025, 11:27 AM EST - 9 months ago

IDEXX Laboratories And Its Real Value

IDEXX Laboratories: I See Pet Healthcare As An Interesting Market For The Future

Feb 6, 2025, 2:31 PM EST - 9 months ago

IDEXX Laboratories: I See Pet Healthcare As An Interesting Market For The Future

Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today's Top S&P 500 Performers.

Feb 3, 2025, 11:31 AM EST - 9 months ago

Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today's Top S&P 500 Performers.

ABBV MOH

IDEXX Laboratories, Inc. (IDXX) Q4 2024 Earnings Call Transcript

Feb 3, 2025, 11:26 AM EST - 9 months ago

IDEXX Laboratories, Inc. (IDXX) Q4 2024 Earnings Call Transcript

IDEXX Laboratories Stock Jumps on Testing Products Demand, Higher Prices

Feb 3, 2025, 11:22 AM EST - 9 months ago

IDEXX Laboratories Stock Jumps on Testing Products Demand, Higher Prices

Why Is Pet Health Company IDEXX Laboratories Stock Trading Higher On Monday?

Feb 3, 2025, 9:51 AM EST - 9 months ago

Why Is Pet Health Company IDEXX Laboratories Stock Trading Higher On Monday?

Animal diagnostics maker IDEXX beats quarterly estimates despite low vet visits

Feb 3, 2025, 7:57 AM EST - 9 months ago

Animal diagnostics maker IDEXX beats quarterly estimates despite low vet visits

IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results

Feb 3, 2025, 6:30 AM EST - 9 months ago

IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results

IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results

Jan 16, 2025, 4:15 PM EST - 10 months ago

IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results

SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX

Dec 19, 2024, 10:09 AM EST - 11 months ago

SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX

SNPS

IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization

Dec 9, 2024, 7:30 AM EST - 11 months ago

IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization

IDEXX Announces CFO Transition

Nov 21, 2024, 7:30 AM EST - 1 year ago

IDEXX Announces CFO Transition

ACVIM and IDEXX Partner to Provide Free Educational Offerings for ACVIM Residents

Nov 12, 2024, 9:00 AM EST - 1 year ago

ACVIM and IDEXX Partner to Provide Free Educational Offerings for ACVIM Residents

IDEXX Laboratories Q3: Weak End-Market Demand Continues

Nov 10, 2024, 7:50 PM EST - 1 year ago

IDEXX Laboratories Q3: Weak End-Market Demand Continues

IDEXX Laboratories, Inc. (IDXX) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 1:59 PM EDT - 1 year ago

IDEXX Laboratories, Inc. (IDXX) Q3 2024 Earnings Call Transcript

CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results

Oct 31, 2024, 1:15 PM EDT - 1 year ago

CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results

Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth

Oct 31, 2024, 12:55 PM EDT - 1 year ago

Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth

IDEXX laboratories cuts annual revenue forecast for third time as pet clinic visits slow

Oct 31, 2024, 8:01 AM EDT - 1 year ago

IDEXX laboratories cuts annual revenue forecast for third time as pet clinic visits slow

IDEXX Laboratories Announces Third Quarter Results

Oct 31, 2024, 6:30 AM EDT - 1 year ago

IDEXX Laboratories Announces Third Quarter Results

IDEXX Laboratories to Release 2024 Third Quarter Financial Results

Sep 30, 2024, 2:00 PM EDT - 1 year ago

IDEXX Laboratories to Release 2024 Third Quarter Financial Results

IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 21, 2024, 4:15 PM EDT - 1 year ago

IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

IDEXX Laboratories Q2: Headwinds From Low U.S. Clinical Visits

Aug 11, 2024, 11:36 PM EDT - 1 year ago

IDEXX Laboratories Q2: Headwinds From Low U.S. Clinical Visits

Animal Health Firm Idexx's Robust Business Model Bolsters Position Despite Slower Growth, Says Analyst

Aug 6, 2024, 12:48 PM EDT - 1 year ago

Animal Health Firm Idexx's Robust Business Model Bolsters Position Despite Slower Growth, Says Analyst

darcypansy2
darcypansy2 Oct. 27 at 10:16 PM
$IDXX $CARR Upper shadow pressure https://stocktwits.com/jaredevans1/message/633847474
0 · Reply
VincentHall3771
VincentHall3771 Oct. 27 at 6:32 PM
$IDXX $CARR Swings initiated https://stocktwits.com/justinaugustus5/message/633849350
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 27 at 3:53 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $IDXX Current Share Price: $640.85 Contracts: $IDXX April 17, 2026 $650 Calls Scale in: $51.28- $62.67 Scale out: $79.77-$102.56 Can Easily Capture: 60% ROI Blended DTE: 173 Days | Join Elites here: https://liquidtheta.com
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 26 at 5:55 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $IDXX Current Share Price: $640.85 Contracts: $IDXX April 17, 2026 $650 Calls Scale in: $51.28- $62.67 Scale out: $79.77-$102.56 Can Easily Capture: 60% ROI Blended DTE: 174 Days | Join Elites here: https://liquidtheta.com
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 24 at 3:54 PM
🏛️ 🚀 $IDXX up ⬆️3.78% since our entry $626.34 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 24 at 3:34 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $IDXX Current Share Price: $639.30 Contracts: $IDXX April 17, 2026 $640 Calls Scale in: $58.66- $71.69 Scale out: $91.24-$117.31 Can Easily Capture: 60% ROI Blended DTE: 176 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 24 at 1:47 PM
$IDXX RSI: 60.09, MACD: 1.3880 Vol: 6.86, MA20: 633.06, MA50: 638.50 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 4:48 AM
Enter: $IDXX NOV 21 2025 $640 CALLS Buy in Price: $30.95 - $35.50 Take Profit: $73.04 Stop Bleeding: $27.24 ROI Potential: 136% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 21 at 11:56 PM
$IDXX Share Price: $636.91 Contract Selected: Apr 17, 2026 $640 Calls Buy Zone: $48.88 – $60.38 Target Zone: $90.48 – $110.58 Potential Upside: 75% ROI Time to Expiration: 177 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ZacksResearch
ZacksResearch Oct. 20 at 1:41 PM
$IDXX heading into Q3 with quiet strength 💪 Steady estimates and solid momentum in diagnostics and pet healthcare signal confidence ahead of earnings. Full pre-earnings breakdown here 👉 https://www.zacks.com/stock/news/2772097/heres-how-idexx-laboratories-is-placed-ahead-of-q3-earnings?cid=sm-stocktwits-2-2772097-teaser-16756&ADID=SYND_STOCKTWITS_TWEET_2_2772097_TEASER_16756
0 · Reply
ZacksResearch
ZacksResearch Oct. 20 at 12:41 PM
$IDXX set for a Q3 earnings beat? 🚀 💡 IDEXX boasts a positive Earnings ESP of +0.23% and holds a Zacks Rank #2. The CAG segment is expected to drive strong results, with the Zacks Consensus Estimate indicating a 10% YoY revenue increase, aided by innovations like the inVue Dx Analyzer. Full Q3 preview here 👉 https://www.zacks.com/stock/news/2772097/heres-how-idexx-laboratories-is-placed-ahead-of-q3-earnings?cid=sm-stocktwits-2-2772097-body-16742&ADID=SYND_STOCKTWITS_TWEET_2_2772097_BODY_16742
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 3:07 AM
Enter: $IDXX NOV 21 2025 $640 CALLS Buy in Price: $30.95 - $36.80 Take Profit: $41.16 Stop Bleeding: $27.24 ROI Potential: 33% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
IceProud2339
IceProud2339 Oct. 19 at 3:45 AM
$IDXX Perfect dip for adding
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 19 at 2:06 AM
Enter: $IDXX NOV 21 2025 $640 CALLS Buy in Price: $30.95 - $36.80 Take Profit: $71.80 Stop Bleeding: $27.24 ROI Potential: 132% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 18 at 6:31 AM
Enter: $IDXX NOV 21 2025 $640 CALLS Buy in Price: $30.95 - $33.80 Take Profit: $60.04 Stop Bleeding: $27.24 ROI Potential: 94% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 18 at 4:46 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $IDXX Current Share Price: $637.34 Contracts: $IDXX April 17, 2026 $640 Calls Scale in: $58.66- $71.69 Scale out: $91.24-$117.31 Can Easily Capture: 60% ROI Blended DTE: 182 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 16 at 10:20 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $IDXX Current Share Price: $639.15 Contracts: $IDXX April 17, 2026 $640 Calls Scale in: $58.66- $71.69 Scale out: $91.24-$117.31 Can Easily Capture: 60% ROI Blended DTE: 183 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 16 at 2:15 PM
Enter: $IDXX NOV 21 2025 $640 CALLS Buy in Price: $36.96 - $38.00 Take Profit: $63.94 Stop Bleeding: $32.52 ROI Potential: 73% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 15 at 8:10 AM
Enter: $IDXX NOV 21 2025 $640 CALLS Buy in Price: $32.90 - $38.30 Take Profit: $76.00 Stop Bleeding: $28.95 ROI Potential: 131% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 14 at 8:17 AM
Enter: $IDXX NOV 21 2025 $640 CALLS Buy in Price: $32.90 - $35.80 Take Profit: $78.30 Stop Bleeding: $28.95 ROI Potential: 138% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 14 at 7:23 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $IDXX Current Share Price: $616.15 Contracts: $IDXX April 17, 2026 $620 Calls Scale in: $59.02- $72.14 Scale out: $91.81-$118.04 Can Easily Capture: 60% ROI Blended DTE: 186 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 13 at 11:42 PM
$IDXX Share Price: $633.12 Contract Selected: Jan 16, 2026 $630 Calls Buy Zone: $38.00 – $46.94 Target Zone: $62.63 – $76.55 Potential Upside: 56% ROI Time to Expiration: 94 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply